In this prospective non-interventional study, the effectiveness and tolerability of erlotinib in elderly patients with non-small-cell lung cancer (NSCLC) after ≥1 platinum-based chemotherapy were assessed. | Erlotinib treatment after platinum-based therapy in elderly patients with non-smallcell lung cancer in routine clinical practice results from the ElderTac study